Syra Health Corp (OTC:SYRA)
| Market Cap | 10.27M+760.0% |
| Revenue (ttm) | 8.09M+0.3% |
| Net Income | 130.75K+109.0% |
| EPS | 0.01+103.6% |
| Shares Out | 11.94M |
| PE Ratio | 95.56 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4 |
| Open | 0.86 |
| Previous Close | 0.83 |
| Day's Range | 0.86 - 0.86 |
| 52-Week Range | 0.06 - 1.15 |
| Beta | 3.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 18, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About SYRA
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
$SYRA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SYRA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SYRA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SYRA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SYRA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SYRA from public contracts
Source: USAspending.gov
SYRA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from SYRA’s recent data — informational, not investment advice
